ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2011 Financial Results

* Reuters is not responsible for the content in this press release.

Fri Jul 15, 2011 7:31am EDT 

  IRVINE, CA, Jul 15 (MARKET WIRE) -- 
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release
second quarter 2011 financial results after the market closes on July 28,
2011. In conjunction, the Company will host a conference call at 4:30
p.m. Eastern Time to review the Company's commercial operations and
provide pipeline updates. 

    Date: Thursday, July 28, 2011 
 Time: 4:30 p.m. Eastern Time

    Conference call access:
 Internet: www.istavision.com
 Domestic dial-in:
866.804.6922
 International dial-in: 857.350.1668
 Passcode: 73568588

    To access the 24-hour audio replay, U.S. and Canadian participants may
dial 888.286.8010; international participants may dial 617.801.6888. The
access code for the replay is 37743515. This conference call also will be
webcast live and archived on ISTA's website until September 4, 2011. 

    About ISTA Pharmaceuticals
 ISTA Pharmaceuticals, Inc. is a fast growing
and the fourth largest branded prescription eye care business in the
United States, with an expanding focus on allergy therapeutics. ISTA
currently markets four products, including treatments for ocular
inflammation and pain post-cataract surgery, glaucoma and ocular itching
associated with allergic conjunctivitis. The company's development
pipeline contains additional candidates in various stages of development
to treat dry eye, ocular inflammation and pain, and nasal allergies.
Headquartered in Irvine, California, ISTA generated revenues of $156.5
million in 2010. For additional information about ISTA, please visit the
corporate website at www.istavision.com.

    

Contacts
Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302 
lsilvernail@istavision.com

Jeanie Herbert
949-789-3159
jherbert@istavision.com

Media and Additional Investor Relations Contacts at Burns McClellan: 
Justin Jackson (Media)
212-213-0006
jjackson@burnsmc.com 

Juliane Snowden (Investor Relations)
212-213-0006
jsnowden@burnsmc.com  

Copyright 2011, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.